| |
TA (n = 19)
|
Placebo (n = 19)
|
P-Value
|
|---|
|
Age (y)
|
55 ± 11
|
60 ± 7
|
0.17
|
|
M/F
|
18/1
|
18/1
|
1.0
|
|
Wt. (Kg)
|
73 ± 15
|
71 ± 14
|
0.74
|
|
BMI
|
27 ± 4
|
27 ± 4
|
1.0
|
|
Smoking
|
6 (31.5%)
|
6 (31.5%)
|
1.0
|
|
Diabetes
|
7 (37%)
|
10 (53%)
|
0.42
|
|
Hypertension
|
7 (37%)
|
12 (63%)
|
0.17
|
|
Hyperchol
|
3 (16%)
|
0 (0%)
|
0.08
|
|
COPD
|
1 (5%)
|
1 (5%)
|
1.0
|
|
RF
|
0 (0%)
|
1 (5%)
|
0.33
|
|
PVD
|
3 (16%)
|
0 (0%)
|
0.08
|
|
Previous MI
|
4 (21%)
|
6 (31.5%)
|
0.42
|
|
LVEF
|
48 ± 10
|
46 ± 10
|
0.49
|
|
Euroscore
|
2.3 ± 1.7
|
2.5 ± 1.6
|
0.58
|
- Values are means ± SD or No.(%) where shown.
- M/F: Male/Female
- Wt.: Weight
- BMI: Body Mass Index
- COPD: Chronic Obstructive Pulmonary Disease
- RF: Renal Failure
- Hyperchol: Hypercholesterolmia
- PVD: Peripheral Vascular Disease
- MI: Myocardial Infarction
- LVEF: Left Ventricular Ejection Fraction
